<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00858442</url>
  </required_header>
  <id_info>
    <org_study_id>1-Quezada</org_study_id>
    <nct_id>NCT00858442</nct_id>
  </id_info>
  <brief_title>Platelet-Rich Plasma (PRP) in Reconstructive Surgery on Children With Retractable Burn Sequelae on Extremities</brief_title>
  <official_title>PRP on Children With Retractable Burn Sequelae Who Have Submitted Release of Burn Contractures and Skin Graft on Their Limbs. A Double-Blind Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporation for the Aid of Burned Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Corporation for the Aid of Burned Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Does the addition of Platelet-Rich Plasma (PRP) to release of burn contractures and skin
      graft on the limbs of children with retractable burn sequelae reduce the initial time of the
      compressive treatment and maintain or lower the graft's retraction?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis:

        1. The use of PRP will allow to initiate sooner the compressive treatment during the post
           graft surgery evolution, in fewer days on average than the traditional method (18 ds).

        2. The use of PRP will maintain the same initial size of the graft. The study's domain
           corresponds to burn sequelae on children in treatment with reconstructive surgery due to
           retractile sequelae located on their upper and lower limbs, with functional compromise
           during their growth process.

      One of the treatments used for this problem is the surgical technique of with release of burn
      contractures and skin graft.

      Split skin grafts are at risk of suboptimal &quot;take&quot; due to bleeding and infection which would,
      on the one hand, delay the initiation of the rehabilitation with preventive compression to
      avoid the retraction of the grafted area.

      20% of the children that arrive in COANIQUEM (approximately 7,000 annually), require
      rehabilitation. Of these, 32% have surgery and 9% of those are release of burn contractures
      and skin graft mainly on extremities.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Median Time Between Surgery Date and Start Date Compression.</measure>
    <time_frame>day</time_frame>
    <description>Participants were followed from the date of surgery and the date of onset of compression for a minimum of 13.5 days and a maximum of 27 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Width of the Graft</measure>
    <time_frame>start and end compression</time_frame>
    <description>Central width measurement graft between the start and the end of the compression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of the Graft</measure>
    <time_frame>start and end compression</time_frame>
    <description>Central length measurement graft between the start and the end of the compression</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>With PRP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient received a single dose of 5cc PRP before the graft.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Without PRP</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control patients did not receive any intervention before the graft.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>With PRP</intervention_name>
    <description>Release of burn contractures and skin graft on the affected limb, a rigorous haemostasis. The surgeon must distribute the activated PRP evenly, forming a very fine clot over it. Immediately the split skin graft must be applied, duly fenestrated. The grafted zone will be measured in it's longest width and length, taking a standardized photograph. On the 5th day the nurse will evaluate the graft's conditions. The evaluation will be done following a previously established follow-up protocol. Measurements of width &amp; length of graft and standardized photo taken at the initiation of the compressive system. Measurement of graft's width &amp; length and standardized photo at the end of the compressive system according protocol. Statistical analysis.</description>
    <arm_group_label>With PRP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with burn sequelae on their upper or lower limbs

          -  Treated with release of burn contractures and skin graft on their upper or lower limbs

          -  Between 5 and 21 years old

          -  Following instructions in their homes

          -  With informed and written consent

          -  Weight 35 Kg or more

          -  Blood count

          -  Hepatic and coagulation tests

          -  Paediatric evaluation prior to surgery

        Exclusion Criteria:

          -  Background of blood alterations

          -  Another current pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M B Quezada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Corporation for the Aid of Burned Children</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Coaniquem</name>
      <address>
        <city>Santiago</city>
        <state>Pudahuel</state>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <link>
    <url>http://www.nlm.nih.gov/medlineplus/</url>
    <description>burns scars</description>
  </link>
  <results_reference>
    <citation>Martínez-Zapata MJ, Martí-Carvajal A, Solà I, Bolibar I, Angel Expósito J, Rodriguez L, García J. Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion. 2009 Jan;49(1):44-56. doi: 10.1111/j.1537-2995.2008.01945.x. Epub 2008 Oct 14. Review.</citation>
    <PMID>18954394</PMID>
  </results_reference>
  <results_reference>
    <citation>Rutkowski JL, Thomas JM, Bering CL, Speicher JL, Radio NM, Smith DM, Johnson DA. Analysis of a rapid, simple, and inexpensive technique used to obtain platelet-rich plasma for use in clinical practice. J Oral Implantol. 2008;34(1):25-33. doi: 10.1563/1548-1336(2008)34[25:AAOARS]2.0.CO;2.</citation>
    <PMID>18390240</PMID>
  </results_reference>
  <results_reference>
    <citation>Pietramaggiori G, Scherer SS, Mathews JC, Alperovich M, Yang HJ, Neuwalder J, Czeczuga JM, Chan RK, Wagner CT, Orgill DP. Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair Regen. 2008 Mar-Apr;16(2):218-25. doi: 10.1111/j.1524-475X.2008.00362.x.</citation>
    <PMID>18318807</PMID>
  </results_reference>
  <results_reference>
    <citation>Rozman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Pannonica Adriat. 2007 Dec;16(4):156-65. Review.</citation>
    <PMID>18204746</PMID>
  </results_reference>
  <results_reference>
    <citation>Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, Moroni M, Carabelli A. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004 Apr;30(2):145-51.</citation>
    <PMID>15062754</PMID>
  </results_reference>
  <results_reference>
    <citation>Kazakos K, Lyras DN, Verettas D, Tilkeridis K, Tryfonidis M. The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury. 2009 Aug;40(8):801-5. doi: 10.1016/j.injury.2008.05.002. Epub 2008 Aug 13.</citation>
    <PMID>18703188</PMID>
  </results_reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2009</study_first_submitted>
  <study_first_submitted_qc>March 5, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2009</study_first_posted>
  <results_first_submitted>April 18, 2013</results_first_submitted>
  <results_first_submitted_qc>January 22, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 26, 2015</results_first_posted>
  <last_update_submitted>January 28, 2015</last_update_submitted>
  <last_update_submitted_qc>January 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporation for the Aid of Burned Children</investigator_affiliation>
    <investigator_full_name>maría beatriz quezada</investigator_full_name>
    <investigator_title>md</investigator_title>
  </responsible_party>
  <keyword>Burn sequelae</keyword>
  <keyword>PRP</keyword>
  <keyword>Children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited on the day of the scheduled surgery. The researcher checked the inclusion criteria. Explained to the parents and patient surgical procedure, risk of complications and are invited to participate voluntarily in the study. Informed consent is signed. They recruited 44 children in total between April 6,2009 and August 9,2011</recruitment_details>
      <pre_assignment_details>Potential candidates to enter the study were 80. Of these, 20 were excluded for having a weight less than 35 kg; 15 for failing to ensure their attendance at the controls and 1 have coagulation disorders</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Without PRP</title>
          <description>This arm did not receive any intervention</description>
        </group>
        <group group_id="P2">
          <title>With PRP</title>
          <description>4 cc of PRP is evenly distributed before the dermo-epidermic draft.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>From Surgery to Start Compression;</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Compression:Start to Finish</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Some patients received more than one graft, as it is shown in result section.</population>
      <group_list>
        <group group_id="B1">
          <title>Without PRP</title>
          <description>Patients with burns sequelae on their limbs treated with release of burns contractures and skin graft between 2008-2010.</description>
        </group>
        <group group_id="B2">
          <title>With PRP</title>
          <description>Patients with burns sequelae on their limbs treated with release of burn contractures and skin graft with PRP between 2008-2010.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="23"/>
            <count group_id="B3" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.5" spread="3.1"/>
                    <measurement group_id="B2" value="14.1" spread="3.5"/>
                    <measurement group_id="B3" value="14.2" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Chile</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Median Time Between Surgery Date and Start Date Compression.</title>
        <description>Participants were followed from the date of surgery and the date of onset of compression for a minimum of 13.5 days and a maximum of 27 days</description>
        <time_frame>day</time_frame>
        <population>A participant may have one, two or three areas grafted</population>
        <group_list>
          <group group_id="O1">
            <title>Without PRP</title>
            <description>Patients did not received plasma enrich platelets</description>
          </group>
          <group group_id="O2">
            <title>With PRP</title>
            <description>Patients received plasma enriched platelets</description>
          </group>
        </group_list>
        <measure>
          <title>Median Time Between Surgery Date and Start Date Compression.</title>
          <description>Participants were followed from the date of surgery and the date of onset of compression for a minimum of 13.5 days and a maximum of 27 days</description>
          <population>A participant may have one, two or three areas grafted</population>
          <units>day</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>grafted area</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" lower_limit="14" upper_limit="24"/>
                    <measurement group_id="O2" value="19" lower_limit="13.5" upper_limit="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Applies normality test of shapiro Wilks = 0.953, P&gt; 0.449 in group without PRP and in PRP group shapiro Wilks=0.946, P &gt; 0.259.
The data were normally distributed, with equal variances (Test of levene: F = 0.1234, P&gt; 0.99)</non_inferiority_desc>
            <p_value>&gt;0.1574</p_value>
            <p_value_desc>Applies t-test for equality of means. t = -1.016 is obtained. p&gt; 0.1574</p_value_desc>
            <method>t-test, 1 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-2.452</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>2.452</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7.332</ci_lower_limit>
            <ci_upper_limit>2.428</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Width of the Graft</title>
        <description>Central width measurement graft between the start and the end of the compression</description>
        <time_frame>start and end compression</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Without PRP</title>
            <description>Patients did not receive plasma enriched platelets</description>
          </group>
          <group group_id="O2">
            <title>With PRP</title>
            <description>Patients received plasma enriched platelets</description>
          </group>
        </group_list>
        <measure>
          <title>Width of the Graft</title>
          <description>Central width measurement graft between the start and the end of the compression</description>
          <units>centimeter</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>grafted areas</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" lower_limit="-0.25" upper_limit="1.35"/>
                    <measurement group_id="O2" value="0.3" lower_limit="-0.5" upper_limit="2.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Applies normality test of shapiro Wilks =0.972, P&gt; 0.687 in group without PRP and in PRP group shapiro Wilks = 0.964, P &gt; 0.410.
The data were normally distributed, with equal variances (Test of levene: F = 3.153, P&gt; 0.082)</non_inferiority_desc>
            <p_value>&gt;0.593</p_value>
            <p_value_desc>Applies t-test for equality of means. t = -0.538 is obtained. p&gt; 0.593</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.27186</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.50519</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.28561</ci_lower_limit>
            <ci_upper_limit>0.74189</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of the Graft</title>
        <description>Central length measurement graft between the start and the end of the compression</description>
        <time_frame>start and end compression</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Without PRP</title>
            <description>Patients did not receive plasma enriched platelets</description>
          </group>
          <group group_id="O2">
            <title>With PRP</title>
            <description>Patients received plasma enriched platelets</description>
          </group>
        </group_list>
        <measure>
          <title>Length of the Graft</title>
          <description>Central length measurement graft between the start and the end of the compression</description>
          <units>centimeter</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>grafted areas</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" lower_limit="-0.95" upper_limit="1.55"/>
                    <measurement group_id="O2" value="0.2" lower_limit="-0.65" upper_limit="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Applies normality test of shapiro Wilks=0.822, P&lt;0.001 in group without PRP, and in PRP group shapiro Wilks =0.910, P&lt;0.017.
The data were no normally distributed, with equal variances (Test of levene, F=1.324, P&gt;0.255)</non_inferiority_desc>
            <p_value>&gt;0.398</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>Mean rank group without PRP= 28.88 Mean rank group with PRP= 26.31 Z value = -0.027</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 months</time_frame>
      <desc>adverse effect is considered the need regrafting bloody small areas.</desc>
      <group_list>
        <group group_id="E1">
          <title>Without PRP</title>
          <description>Patients did not receive plasma enriched platelets</description>
        </group>
        <group group_id="E2">
          <title>With PRP</title>
          <description>Patients received plasma enriched platelets</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>regrafting</sub_title>
                <description>adverse effect is considered the need regrafting bloody small areas</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Loss cases: PRP group: 3/23 and group without PRP: 1/21</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>M Beatriz Quezada.MD</name_or_title>
      <organization>coaniquem</organization>
      <phone>56-2-28734077</phone>
      <email>investigacion@coaniquem.cl</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

